Wedbush Downgrades UWM Holdings to Neutral, Raises Price Target to $10
Wedbush analyst Henry Coffey downgrades UWM Holdings (NYSE:UWMC) from Outperform to Neutral and raises the price target from $9.25 to $10.
Evercore ISI Group Downgrades AvalonBay Communities to In-Line
Evercore ISI Group analyst Steve Sakwa downgrades AvalonBay Communities (NYSE:AVB) from Outperform to In-Line.
Evercore ISI Group Downgrades Equity Residential to In-Line
Evercore ISI Group analyst Steve Sakwa downgrades Equity Residential (NYSE:EQR) from Outperform to In-Line.
DA Davidson Downgrades First Bancshares to Neutral, Raises Price Target to $44.5
DA Davidson analyst Kevin Fitzsimmons downgrades First Bancshares (NASDAQ:FBMS) from Buy to Neutral and raises the price target from $44 to $44.5.
Evercore ISI Group Downgrades Camden Prop Trust to In-Line
Evercore ISI Group analyst Richard Hightower downgrades Camden Prop Trust (NYSE:CPT) from Outperform to In-Line.
Citigroup Downgrades Core Laboratories to Sell, Raises Price Target to $36
Citigroup analyst Scott Gruber downgrades Core Laboratories (NYSE:CLB) from Neutral to Sell and raises the price target from $30 to $36.
Baird Downgrades Physicians Realty Trust to Neutral, Raises Price Target to $20
Baird analyst Amanda Sweitzer downgrades Physicians Realty Trust (NYSE:DOC) from Outperform to Neutral and raises the price target from $19 to $20.
Goldman Sachs Downgrades Ferrari to Sell, Announces $207 Price Target
Goldman Sachs analyst George Galliers downgrades Ferrari (NYSE:RACE) from Buy to Sell and announces $207 price target.
Goldman Sachs Downgrades Kinder Morgan to Sell
Goldman Sachs analyst Michael Lapides downgrades Kinder Morgan (NYSE:KMI) from Neutral to Sell.